» Articles » PMID: 37957462

Relevance and Consequence of Chronic Inflammation for Obesity Development

Overview
Publisher Springer
Specialty Pediatrics
Date 2023 Nov 13
PMID 37957462
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Increasing prevalence of morbid obesity accompanied by comorbidities like type 2 diabetes mellitus (T2DM) led to a demand for improving therapeutic strategies and pharmacological intervention options. Apart from genetics, inflammation processes have been hypothesized to be of importance for the development of obesity and related aspects like insulin resistance.

Main Text: Within this review, we provide an overview of the intricate interplay between chronic inflammation of the adipose tissue and the hypothalamus and the development of obesity. Further understanding of this relationship might improve the understanding of the underlying mechanism and may be of relevance for the establishment of new treatment strategies.

Citing Articles

Dose-Dependent Effects of Short-Chain Fatty Acids on 3T3-L1 Adipocyte Adipokine Secretion and Metabolic Function.

Alzubi A, Glowacki H, Burns J, Van K, Martin J, Monk J Nutrients. 2025; 17(3).

PMID: 39940429 PMC: 11820615. DOI: 10.3390/nu17030571.


Association of relative fat mass with asthma: inflammatory markers as potential mediators.

Zhou M, Zhang T, Zeng Z, Zeng S, Wang S, Wang H Lipids Health Dis. 2025; 24(1):13.

PMID: 39810140 PMC: 11731360. DOI: 10.1186/s12944-024-02428-y.


Effect of Comparable Carbon Chain Length Short- and Branched-Chain Fatty Acids on Adipokine Secretion from Normoxic and Hypoxic Lipopolysaccharide-Stimulated 3T3-L1 Adipocytes.

Alzubi A, Monk J Biomedicines. 2024; 12(11).

PMID: 39595185 PMC: 11592336. DOI: 10.3390/biomedicines12112621.


Unraveling the Interaction between Inflammation and the Cardiometabolic Index in Older Men: A Pilot Study.

Carvalho R, Brito T, Amaral J, Monteiro F, Lima D, Pereira T Nutrients. 2024; 16(15).

PMID: 39125408 PMC: 11313730. DOI: 10.3390/nu16152529.


Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers.

Kallinich T, Mall M Mol Cell Pediatr. 2024; 11(1):5.

PMID: 38837027 PMC: 11153465. DOI: 10.1186/s40348-024-00177-7.


References
1.
Defuria J, Belkina A, Jagannathan-Bogdan M, Snyder-Cappione J, Carr J, Nersesova Y . B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013; 110(13):5133-8. PMC: 3612635. DOI: 10.1073/pnas.1215840110. View

2.
Winer D, Winer S, Shen L, Wadia P, Yantha J, Paltser G . B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011; 17(5):610-7. PMC: 3270885. DOI: 10.1038/nm.2353. View

3.
Lebrun L, Lenaerts K, Kiers D, Pais de Barros J, Le Guern N, Plesnik J . Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion. Cell Rep. 2017; 21(5):1160-1168. DOI: 10.1016/j.celrep.2017.10.008. View

4.
Ruscitti P, Masedu F, Alvaro S, Airo P, Battafarano N, Cantarini L . Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial. PLoS Med. 2019; 16(9):e1002901. PMC: 6742232. DOI: 10.1371/journal.pmed.1002901. View

5.
Bates H, Campbell J, Ussher J, Baggio L, Maida A, Seino Y . Gipr is essential for adrenocortical steroidogenesis; however, corticosterone deficiency does not mediate the favorable metabolic phenotype of Gipr(-/-) mice. Diabetes. 2011; 61(1):40-8. PMC: 3237652. DOI: 10.2337/db11-1060. View